“Almost 10 years ago, the FDA approved recombinant human bone morphogenetic protein-2, or BMP-2, a biologic agent that could grow bone where none existed. But despite the commercial success of the product, a number of safety concerns have emerged over time, including — as this special report from the Milwaukee Journal Sentinel/MedPage Today reveals — a link to a condition that causes sterility in men.”

Click link for full story